Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin

• Kageaki Watanabe, MD,
• Rui Kitadai, MD,
• Shingo Kitagawa, MD,
• Takashi Toya, MD,
• Yukio Hosomi, MD, PhD

Affiliations

Kageaki Watanabe, MD

Corresponding author. Address for correspondence: Kageaki Watanabe, MD, Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan.; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan

Rui Kitadai, MD

Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan

Shingo Kitagawa, MD

Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan

Takashi Toya, MD

Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan

Yukio Hosomi, MD, PhD

Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan